Deutsche Bank
TRIB

Deutsche Bank’s Trinity Biotech TRIB Stock Holding History

Deutsche Bank’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,496
Closed -$9K – 5137
2019
Q3 		$9K Sell
1,496
-11,544
-89% -$100K ﹤0.01% 4540
2019
Q2 		$107K Buy
13,040
+4,740
+57% +$56.4K ﹤0.01% 4176
2019
Q1 		$118K Sell
8,300
-920
-10% -$12.6K ﹤0.01% 4237
2018
Q4 		$105K Sell
9,220
-8,776
-49% -$135K ﹤0.01% 4205
2018
Q3 		$360K Buy
17,996
+1,138
+7% +$24.7K ﹤0.01% 3955
2018
Q2 		$421K Buy
16,858
+4,704
+39% +$113K ﹤0.01% 3932
2018
Q1 		$312K Buy
12,154
+4,215
+53% +$115K ﹤0.01% 3969
2017
Q4 		$202K Buy
+7,939
New +$205K ﹤0.01% 4029
2017
Q3 		– Hold
0
– – – 5086
2017
Q2 		– Hold
0
– – – 5120
2017
Q1 		– Sell
-143
Closed -$4.47K – 5101
2016
Q4 		$4K Sell
143
-6,607
-98% -$228K ﹤0.01% 4770
2016
Q3 		$446K Buy
6,750
+6,568
+3,609% +$409K ﹤0.01% 3258
2016
Q2 		$10K Sell
182
-4,130
-96% -$233K ﹤0.01% 4913
2016
Q1 		$251K Buy
4,312
+4,293
+22,595% +$228K ﹤0.01% 3550
2015
Q4 		$1K Sell
19
-19,236
-100% -$1.14M ﹤0.01% 5202
2015
Q3 		$1.1M Buy
19,255
+9,377
+95% +$754K ﹤0.01% 2880
2015
Q2 		$890K Buy
9,878
+4,910
+99% +$425K ﹤0.01% 3042
2015
Q1 		$477K Sell
4,968
-140
-3% -$12.9K ﹤0.01% 3319
2014
Q4 		$446K Buy
5,108
+1,812
+55% +$156K ﹤0.01% 3749
2014
Q3 		$301K Sell
3,296
-227
-6% -$24.6K ﹤0.01% 3828
2014
Q2 		$405K Buy
3,523
+1,231
+54% +$146K ﹤0.01% 3621
2014
Q1 		$277K Buy
2,292
+1,892
+473% +$248K ﹤0.01% 3712
2013
Q4 		$50K Sell
400
-419
-51% -$50.3K ﹤0.01% 4353
2013
Q3 		$88K Sell
819
-3,210
-80% -$313K ﹤0.01% 4475
2013
Q2 		$339K Buy
+4,029
New +$334K ﹤0.01% 3420

Other funds holding TRIB

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Deutsche Bank's TRIB Position: Q4 2019 in Review

Deutsche Bank sold out of Trinity Biotech (TRIB) in Q4 2019, closing a stake of 1,496 shares — an estimated $9K sold.

Deutsche Bank first reported a position in TRIB in Q2 2013 and held it in 23 quarters. The position peaked at $1.1M in Q3 2015. 26 funds tracked by Wall St. Rank hold TRIB as of Q4 2019.

  • Deutsche Bank reported no remaining Trinity Biotech position as of Q4 2019 after selling out during the quarter.
  • Deutsche Bank sold 1,496 Trinity Biotech shares in Q4 2019, an estimated $9K.
  • Deutsche Bank first reported a position in Trinity Biotech in Q2 2013 and held it in 23 quarters.
  • Deutsche Bank's Trinity Biotech position peaked at $1.1M in Q3 2015.
  • 26 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2019.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.